Novonesis is a global leader in biosolutions, formed in January 2024 through the merger of Novozymes and Chr. Hansen. The company develops and sells enzymes, functional proteins, and microorganisms for various industries. It leverages biology to create sustainable solutions for healthier lives and a healthier planet, serving over 30 industries across 130 markets worldwide.